Use of biofluorescence imaging to compare the distribution of certolizumab pegol, adalimumab, and infliximab in the inflamed paws of mice with collagen-induced arthritis. [electronic resource]
Producer: 20090921Description: 36-41 p. digitalISSN:- 1872-7905
- Adalimumab
- Animals
- Anti-Inflammatory Agents -- analysis
- Antibodies, Monoclonal -- analysis
- Antibodies, Monoclonal, Humanized
- Arthritis, Experimental -- drug therapy
- Certolizumab Pegol
- Collagen Type II -- pharmacology
- Fluorescence
- Immunoglobulin Fab Fragments -- analysis
- Infliximab
- Male
- Mice
- Mice, Inbred DBA
- Polyethylene Glycols -- analysis
- Tissue Distribution
- Tumor Necrosis Factor-alpha -- antagonists & inhibitors
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.